Here's Why Pediatrix Medical Group (MD) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should You Buy, Sell or Hold Pediatrix Medical Stock at a 9.28X P/E?
Stable same-facility patient volume growth, inorganic initiatives and transition to an RCM structure should aid MD's future growth.
Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Despite Fast-paced Momentum, Pediatrix Medical Group (MD) Is Still a Bargain Stock
Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Pediatrix Medical Group (MD) Is Attractively Priced Despite Fast-paced Momentum
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Pediatrix Medical Stock Soars 30.5% Since Q3 Earnings Beat
MD expects transformational and restructuring-related expenses to be $48 million in 2024.
Pediatrix Medical Group, Inc. (MD) Q3 2024 Earnings Call Transcript
Pediatrix Medical Group, Inc. (NYSE:MD ) Q3 2024 Earnings Conference Call November 1, 2024 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance and Strategy James Swift - Chief Executive Officer Kasandra Rossi - Executive Vice President, Chief Financial Officer and Treasure Conference Call Participants Jack Senft - William Blair Jack Slevin - Jefferies A.J. Rice - UBS Operator Ladies and gentlemen, thank you for standing by and welcome to the 2024 Third Quarter's Earnings Conference.
Pediatrix Medical Group (MD) Surpasses Q3 Earnings and Revenue Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.32 per share a year ago.
Pediatrix Medical Group (MD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Pediatrix Medical Group (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pediatrix Medical Up 45.8% in 3 Months: Is it Too Late to Jump In?
MD remains one of the best-positioned pediatric service providers with favorable valuation to achieve margin improvement.
Pediatrix Medical Group (MD)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, Pediatrix Medical Group, Inc. (MD) could be a good stock pick from a technical perspective. MD recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Why Is Pediatrix Medical Group (MD) Up 9.5% Since Last Earnings Report?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
